Andrew S. Goldstein

Andrew S. Goldstein

Auto-generated profile, based on publicly available information

Andrew S. Goldstein

Department of Molecular Cell, and Developmental Biology University of California Los Angeles Los Angeles California USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2010 in Science
Verified
Journal Article
Closed access
PDF file
AGAndrew S. Goldstein
Andrew S. Goldstein
JHJiaoti Huang
Jiaoti Huang
CGChangyong Guo
Changyong Guo
IGIsla P. Garraway
Isla P. Garraway
OWOwen N. Witte
Owen N. Witte
Another Cell Culprit in Prostate Cancer: A recent controversial hypothesis about the cellular origins of human cancer, the so-called “cancer stem cell hypothesis,” has fueled interest in identifying the specific cell types that give rise to common epithelial cancers. A single, well-defined cell of origin could, in principle, lead to more effective targeted therapies. Based on histological evidence and/or studies of mouse tumors, luminal cells are believed to be the cell of origin in prostate cancer. Now, using functional assays of cells derived from benign human prostate tissue, Goldstein et al. (p. 568 ) find that a different cell type, basal cells, can give rise in mice to prostate tumors that closely resemble human prostate tumors. Thus, the cellular origin of prostate cancer may be more complex than anticipated.

30 December 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AGAndrew S. Goldstein
Andrew S. Goldstein
DLDevon A. Lawson
Devon A. Lawson
DCDonghui Cheng
Donghui Cheng
WSWenyi Sun
Wenyi Sun
IGIsla P. Garraway
Isla P. Garraway
OWOwen N. Witte
Owen N. Witte
The epithelium of the adult prostate contains 3 distinct cell types: basal, luminal, and neuroendocrine. Tissue-regenerative activity has been identified predominantly from the basal cells, isolated by expression of CD49f and stem cell antigen-1 (Sca-1). An important question for the field is whether all basal cells have stem cell characteristics. Prostate-specific microarray databases were interrogated to find candidate surface antigens that could subfractionate the basal cell population. Tumor-associated calcium signal transducer 2 (TACSTD2/Trop2/M1S1/GA733-1) was identified because it was enriched after castration, in prostate sphere cells and in the basal fraction. In the murine prostate, Trop2 shows progenitor characteristics such as localization to the region of the gland proximal to the urethra and enrichment for sphere-forming and colony-forming cells. Trop2 subfractionates the basal cells into 2 populations, both of which express characteristic basal cell markers by quantitative PCR. However, only the basal cells expressing high levels of Trop2 were able to efficiently form spheres in vitro. In the human prostate, where Sca-1 is not expressed, sphere-forming progenitor cells were also isolated based on high expression of Trop2 and CD49f. Trop2-expressing murine basal cells could regenerate prostatic tubules in vivo, whereas the remaining basal cells had minimal activity. Evidence was found for basal, luminal, and neuroendocrine cells in prostatic tubules regenerated from Trop2 hi basal cells. In summary, functionally distinct populations of cells exist within the prostate basal compartment and an epithelial progenitor can give rise to neuroendocrine cells in vivo.

28 July 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YZYang Zong
Yang Zong
LXLi Xin
Li Xin
AGAndrew S. Goldstein
Andrew S. Goldstein
DLDevon A. Lawson
Devon A. Lawson
MTMichael A. Teitell
Michael A. Teitell
OWOwen N. Witte
Owen N. Witte
Chromosomal rearrangements involving erythroblast transformation specific (ETS) family transcription factors were recently defined as the most common genetic alterations in human prostate cancer. Despite their prevalence, it is unclear what quantitative role they play in either initiation or progression of the disease. Using a lentiviral transduction and dissociated cell prostate regeneration approach, we find that acutely increased expression of ETS proteins in adult murine prostate epithelial cells is sufficient to induce the formation of epithelial hyperplasia and focal prostatic intraepithelial neoplasia (PIN) lesions, but not progression to carcinoma. However, combined expression of ERG with additional genetic alternations associated with human prostate cancer can lead to aggressive disease. Although ERG overexpression does not cooperate with loss of the tumor suppressor p53, it does collaborate with alterations in PI3K signaling, such as Pten knockdown or AKT up-regulation, to produce a well-differentiated adenocarcinoma. Most striking is our finding that overexpression of androgen receptor (AR) does not give rise to any hyperplastic lesions, but when combined with high levels of ERG, it promotes the development of a more poorly differentiated, invasive adenocarcinoma. These findings suggest that in human prostate cancer, the most potent function of ETS gene fusions may be to synergize with alternative genetic events and provide different pathways for carcinoma production and invasive behavior. Our results provide direct evidence for selective cooperating events in ERG-induced prostate tumorigenesis and offer a rational basis for combined therapeutic interventions against multiple oncogenic pathways in prostate cancer.

25 March 2010 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
RLRita U Lukacs
Rita U Lukacs
AGAndrew S Goldstein
Andrew S Goldstein
DLDevon A Lawson
Devon A Lawson
DCDonghui Cheng
Donghui Cheng
OWOwen N Witte
Owen N Witte

26 November 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TSTanya Stoyanova
Tanya Stoyanova
ACAaron R. Cooper
Aaron R. Cooper
JDJustin Drake
Justin Drake
XLXian Liu
Xian Liu
AAAndrew J. Armstrong
Andrew J. Armstrong
AGAndrew S. Goldstein
Andrew S. Goldstein
Significance: This study determined that two histological phenotypes of cancer can arise from a common target cell. Whereas luminal cells are not efficient cells of origin, luminal-like tumor cells isolated from human prostate adenocarcinoma can serially propagate advanced disease.

15 October 2012 in Genes & Development
Verified
Journal Article
Open access
PDF file
TSTanya Stoyanova
Tanya Stoyanova
AGAndrew S. Goldstein
Andrew S. Goldstein
HCHoujian Cai
Houjian Cai
JDJustin Drake
Justin Drake
JHJiaoti Huang
Jiaoti Huang
OWOwen N. Witte
Owen N. Witte
The cell surface protein Trop2 is expressed on immature stem/progenitor-like cells and is overexpressed in many epithelial cancers. However the biological function of Trop2 in tissue maintenance and tumorigenesis remains unclear. In this study, we demonstrate that Trop2 is a regulator of self-renewal, proliferation, and transformation. Trop2 controls these processes through a mechanism of regulated intramembrane proteolysis that leads to cleavage of Trop2, creating two products: the extracellular domain and the intracellular domain. The intracellular domain of Trop2 is released from the membrane and accumulates in the nucleus. Heightened expression of the Trop2 intracellular domain promotes stem/progenitor self-renewal through signaling via β-catenin and is sufficient to initiate precursor lesions to prostate cancer in vivo. Importantly, we demonstrate that loss of β-catenin or Trop2 loss-of-function cleavage mutants abrogates Trop2-driven self-renewal and hyperplasia in the prostate. These findings suggest that heightened expression of Trop2 is selected for in epithelial cancers to enhance the stem-like properties of self-renewal and proliferation. Defining the mechanism of Trop2 function in self-renewal and transformation is essential to identify new therapeutic strategies to block Trop2 activation in cancer.